120
Participants
Start Date
December 21, 2021
Primary Completion Date
January 31, 2025
Study Completion Date
June 30, 2025
Sodium Valproate, Bezafibrate, Medroxyprogesterone
Sodium valproate tablet 1 x 500mg bd, (starting 1 x 200mg bd) Bezafibrate standard release tablet 2 x 200mg tds, (starting 1 x 200mg tds) Medroxyprogesterone acetate tablet 1 x 400mg bd (starting 1 x 400mg od)
Danazol
Danazol 1 x 200mg capsules tds, (starting 1 x 200mg od)
RECRUITING
Heartlands Hospital, Birmingham
RECRUITING
Royal Cornwall Hospital NHS Trust, Truro
RECRUITING
University Hospitals Dorset NHS Foundation Trust, Poole
RECRUITING
Russells Hall Hospital, Dudley
RECRUITING
University College London Hospitals NHS Foundation Trust, London
RECRUITING
King's College Hospital NHS Foundation Trust, London
RECRUITING
Broomfield Hospital, Chelmsford
RECRUITING
Colchester General Hospital, Colchester
RECRUITING
Basingstoke and North Hampshire Hospital,, Basingstoke
RECRUITING
Royal Hampshire County Hospital, Hampshire Hospitals NHS Foundation Trust, Winchester
RECRUITING
East Kent Hospitals University Foundation Trust, Canterbury
RECRUITING
James Paget University Hospitals NHS Foundation Trust, Gorleston-on-Sea
RECRUITING
Nottingham City Hospital, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham
RECRUITING
Grampian Health Board, Aberdeen
RECRUITING
Good Hope Hospital, Birmingham
RECRUITING
Hull University Teaching Hospitals, Hull
RECRUITING
Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester
RECRUITING
James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough
RECRUITING
Royal Gwent Hospital, Aneurin Bevan University Health Board, Newport
Blood Cancer UK
UNKNOWN
Dudley Group NHS Foundation Trust
OTHER
University of Birmingham
OTHER
University of Manchester
OTHER
King's College Hospital NHS Trust
OTHER
Prof. Janet Dunn
OTHER